Tergynan treatment of bacterial vaginosis (BV) and urogenital candidosis (UGC)

E. F. Kira

Journal of obstetrics and women's diseases ›› 1998, Vol. 47 ›› Issue (2) : 27 -30.

PDF
Journal of obstetrics and women's diseases ›› 1998, Vol. 47 ›› Issue (2) : 27 -30. DOI: 10.17816/JOWD87194
Original study articles
research-article

Tergynan treatment of bacterial vaginosis (BV) and urogenital candidosis (UGC)

Author information +
History +
PDF

Abstract

The data about treatment of BV and UGC by local application combined preparation of tergynan are submitted in the article. Efficiency of application of tergynan was compared with approved methods of treatment given diseases with using of 2% dalacin-vaginal cream (n=30) and jenamasolum (n=13). Was established that treatment BV was ascertained at 82,8% and UGC at 63,3% patients. Relapces were marked in 3 months after the ending of treatment accordingly at 18,8% patients with BV and 18,7% patients with UGC.

It is recommended to apply tergynan for treatment BV, UGC and to preventive maintenance of infectious complications after labor, abortions and vaginal’s operations.

Keywords

terginan / bacterial vaginosis / urogenital candidiasis / childbirth / abortions / vaginal surgeries

Cite this article

Download citation ▾
E. F. Kira. Tergynan treatment of bacterial vaginosis (BV) and urogenital candidosis (UGC). Journal of obstetrics and women's diseases, 1998, 47(2): 27-30 DOI:10.17816/JOWD87194

登录浏览全文

4963

注册一个新账户 忘记密码

References

RIGHTS & PERMISSIONS

Eсо-Vector

AI Summary AI Mindmap
PDF

78

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/